Sanofi says dengue vaccine works; 2015 launch anticipated
This article was originally published in Scrip
Executive Summary
Sanofi Pasteur, the vaccines division of Sanofi, has reported that its dengue fever vaccine has reached the primary endpoint in the first of two Phase III pivotal trials of the compound.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.